Transmural heterogeneity of ventricular repolarization under baseline and long QT conditions in the canine heart in vivo: Torsades de pointes develops with halothane but not pentobarbital anesthesia

Journal of Cardiovascular Electrophysiology

Volumn 11, Issue 3, 2000, Pages 290-304

  Weissenburger, Jacques ^b   Nesterenko, Vladislav V ^a   Antzelevitch, Charles ^a  

^a MASONIC MEDICAL RESEARCH LABORATORY   (United States)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

Electrophysiology; Long QT syndrome; M cell; Monophasic action potential

Indexed keywords

HALOTHANE; PENTOBARBITAL; SOTALOL;

ACTION POTENTIAL; ARTICLE; CONTROLLED STUDY; DOG; EXTRASYSTOLE; FEMALE; HEART ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; HEART REPOLARIZATION; IN VIVO STUDY; LONG QT SYNDROME; MALE; NONHUMAN; PRIORITY JOURNAL; TORSADE DES POINTES;

EID: 0034105672     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2000.tb01798.x     Document Type: Article

References (60)

1. Burgess MJ, Green LS, Millar K, Wyatt RF, Abildskov JA: The sequence of normal ventricular recovery. Am Heart J 1972;84:660-669.
2. Sicouri S, Antzelevitch C: A subpopulation of cells with unique electrophysiological properties in the deep subepicardium of the canine ventricle: The M cell. Circ Res 1991;68:1729-1741.
3. Antzelevitch C, Shimizu W, Yan GX, Sicouri S, Weissenburger J, Nesterenko VV, Burashnikov A, Di Diego JM, Saffitz JE, Thomas GP: The M cell. Its contribution to the ECG and to normal and abnormal electrical function of the heart. J Cardiovasc Electrophysiol 1999;10:1124-1152.
4. El-Sherif N, Chinushi M, Caref EB, Restivo M: Electrophysiological mechanism of the characteristic electrocardiographic morphology of torsade de pointes tachyarrhythmias in the long-QT syndrome. Detailed analysis of ventricular tridimensional activation patterns. Circulation 1997;96:4392-4399.
5. Chinushi M, Restivo M, Caref EB, El-Sherif N: The electrophysiological basis of arrhythmogenicity of QT/T alternans in the long QT syndrome: Tridimensional analysis of the kinetics of cardiac repolarization. Circ Res 1998;83:614-628.
6. Weissenburger J, Nesterenko VV, Antzelevitch C: Intramural monophasic action potentials (MAP) display steeper APD-rate relations and higher sensitivity to Class III agents than epicardial and endocardial MAPs: Characteristics of the M cell in vivo. (Abstract) Circulation 1995;92:I-300.
7. Anyukhovsky EP, Sosunov EA, Rosen MR: Regional differences in electrophysiologic properties of epicardium, midmyocardium and endocardium: In vitro and in vivo correlations. Circulation 1996;94:1981-1988.
8. Sosunov EA, Anyukhovsky EP, Rosen MR: Effects of quinidine on repolarization in canine epicardium, midmyocardium, and endocardium. I. In vitro study. Circulation 1997;96:4011-4018.
9. Dessertenne F: La tachycardie ventriculaire a deux foyers opposes variables. Arch Mal Coeur Vaiss 1966;59:263-272.
10. Bonatti V, Finardi A, Botti G: Enregistrements des potentiels d'action monophasiques du ventricule droit dans un cas de QT long et alternance isolee de l'onde U. Arch Mal Coeur Vaiss 1979;72:1180-1186.
11. El-Sherif N, Bekheit SS, Henkin R: Quinidine-induced long QTU interval and torsade de pointes: Role of bradycardia-dependent early afterdepolarizations. J Am Coll Cardiol 1989;14:252-257.
12. Shimizu W, Ohe T, Kurita T, Tokuda T, Shimomura K: Epinephrine-induced ventricular premature complexes due to early afterdepolarizations and effects of verapamil and propranolol in a patient with congenital long QT syndrome. J Cardiovasc Electrophysiol 1994;5:438-444.
13. Strauss HC, Bigger JT, Hoffman BF: Electrophysiological and beta-receptor blocking effects of MJ 1999 on dog and rabbit cardiac tissue. Circ Res 1970;26:661-678.
14. January CT, Shorofsky SR: Early afterdepolarizations: Newer insights into cellular mechanisms. J Cardiovasc Electrophysiol 1990;2:161-169.
15. Motté G, Coumel P, Abitbol G, Dessertenne F, Slama R: Le syndrome QT long et syncopes par "torsades de pointes." Arch Mal Coeur Vaiss 1970;63:831-853.
16. Surawicz B: Electrophysiologic substrate of torsade de pointes: Dispersion of repolarization or early afterdepolarizations? J Am Coll Cardiol 1989;14:172-184.
17. Hii JTY, Wyse DG, Gillis AM, Duff HF, Solylo MA, Mitchell LB: Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone. Circulation 1992;86:1376-1382.
18. Shimizu W, Antzelevitch C: Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade de pointes in LQT2 and LQT3 models of the long-QT syndrome. Circulation 1997;96:2038-2047.
19. Shimizu W, Antzelevitch C: Cellular basis for the electrocardiographic features of the LQT1 form of the long QT syndrome: Effects of β-adrenergic agonists, antagonists and sodium channel blockers on transmural dispersion of repolarization and torsade de pointes. Circulation 1998;98:2314-2322.
20. Yan GX, Antzelevitch C: Cellular basis for the normal T wave and the electrocardiographic manifestations of the long QT syndrome. Circulation 1998;98:1928-1936.
21. Antzelevitch C, Sun ZQ. Zhang ZQ, Yan GX: Cellular and ionic mechanisms underlying erythromycin-induced long QT and torsade de pointes. J Am Coll Cardiol 1996;28:1836-1848.
22. Antzelevitch C, Yan GX, Shimizu W, Burashnikov A: Electrical heterogeneity, the ECG, and cardiac arrhythmias. In Zipes DP, Jalife J, eds: Cardiac Electrophysiology: From Cell to Bedside. Third Edition. WB Saunders, Philadelphia, 1999. pp. 222-238.
23. Yan GX, Shimizu W, Antzelevitch C: Characteristics and distribution of M cells in arterially-perfused canine left ventricular wedge preparations. Circulation 1998;98:1921-1927.
24. El-Sherif N, Caref EB, Yin H, Restivo M: The electrophysiological mechanism of ventricular arrhythmias in the long QT syndrome: Tridimensional mapping of activation and recovery patterns. Circ Res 1996;79:474-492.
25. Burashnikov A, Antzelevitch C: Acceleration-induced action potential prolongation and early afterdepolarizations. J Cardiovasc Electrophysiol 1998;9:934-948.
26. Nesterenko VV: Re-interpretation of the monophasic action potential: Computer model suggests an approach to increase stability and resolution of epicardial and transmural signals. (Abstract) Circulation 1995;92:I-300.
27. Nesterenko VV, Weissenburger J: Experimental evidence for reinterpretation of basis for the monophasic action potential: A new technique with large amplitude and stable transmural signals. (Abstract) Circulation 1995;92:I-299.
28. a properties. J Cardiovasc Electrophysiol 1994;5:711-721.
29. Horner SM, Vespalcova Z, Lab MJ: Electrode for recording direction of activation, conduction velocity, and monophasic action potential of myocardium. Am J Physiol 1997;272:H1917-H1927.
30. Franz MR: Long-term recording of monophasic action potentials from human endocardium. Am J Cardiol 1983;51:1629-1634.
31. Haws CW, Lux RL: Correlation between in vivo transmembrane action potential durations and action-recovery intervals from electrograms. Effects of interventions that alter repolarization time. Circulation 1990;81:281-288.
32. Steinhaus BM: Estimating cardiac transmembrane activation and recovery times from unipolar and bipolar extracellular electrograms: A simulation study. Circ Res 1989;64:449-462.
33. K-ATP activation induce a transmural dispersion of repolarization resulting in ST segment elevation and arrhythmias. (Abstract) PACE 1997;20:1134.
34. Abildskov JA: The sequence of normal recovery of excitability in the dog heart. Circulation 1975;52:442-451.
35. Anyukhovsky EP, Sosunov EA, Feinmark SJ, Rosen MR: Effects of quinidine on repolarization in canine epicardium, midmyocardium, and endocardium. II. In vivo study. Circulation 1997;96:4019-4026.
36. Burashnikov A, Antzelevitch C: Differences in the response of four canine ventricular cell types to α1 adrenergic agonists. (Abstract) PACE 1997;20(Pt II):1115.
37. Shimizu W, Antzelevitch C: Differential effects of β-adrenergic agonists and antagonists on transmural dispersion of repolarization and torsade de pointes in LQT1. LQT2 and LQT3 models of the long QT syndrome. (Abstract) Circulation 1998;98:I-10.
38. Durrer D, Van der Tweel LH, Berreklouw S, Van der Wey AP: Spread of activation in the left ventricular wall of the dog. IV: Two and three dimensional analysis. Am Heart J 1955;50:860-882.
39. Shimizu W, Antzelevitch C: Cellular and ionic basis for T wave alternans under long QT conditions. Circulation 1999;99:1499-1507.
40. Antzelevitch C, Nesterenko VV, Shimizu W, Di Diego JM: Electrophysiological characteristics of the M cell. In Franz MR, Schmitt C, Zrenner B, eds: Monophasic Action Potentials. Springer, Berlin, 1997, pp. 212-226.
41. Antzelevitch C: The M cell. (Editorial Comment) J Cardiovasc Pharmacol Ther 1997;2:73-76.
42. Sosunov EA, Anyukhovsky EP, Rosen MR: Comparison of repolarization of cells from different layers of myocardium in vitro and in vivo. (Abstract) Biophys J 1996;70(Pt 2):A276.
43. Freigang KD, Becker R, Bauer A, Voss F, Senges J, Brachmann J: Electrophysiological properties of individual muscle layers in the in vivo canine heart. (Abstract) J Am Coll Cardiol 1996;27(Suppl A):124A.
44. Antzelevitch C, Sicouri S, Litovsky SH, Lukas A, Krishnan SC, Di Diego JM, Gintant GA, Liu DW: Heterogeneity within the ventricular wall: Electrophysiology and pharmacology of epicardial, endocardial and M cells. Circ Res 1991;69:1427-1449.
45. Sicouri S, Antzelevitch C: Drug-induced afterdepolarizations and triggered activity occur in a discrete subpopulation of ventricular muscle cell (M cells) in the canine heart: Quinidine and digitalis. J Cardiovasc Electrophysiol 1993;4:48-58.
46. Sicouri S, Moro S, Elizari MV: d-Sotalol induces marked action potential prolongation and early afterdepolarizations in M but not epicardial or endocardial cells of the canine ventricle. J Cardiovasc Pharmacol Ther 1997;2:27-38.
47. Hafner D, Berger F, Borchard U, Kullmann A, Scherlitz A. Electrophysiological characterization of the class III activity of sotalol and its enantiomers. New interpretation of use-dependent effects. Arzneimittelforschung 1988;38:231-236.
48. Funk-Brentano C, Silberstein DJ, Roden DM, Wood AJ, Woosley RL: A mechanism of D-(+)-sotalol effects on heart rate not related to beta-adrenoceptor antagonism. Br J Clin Pharmacol 1990;30:195-202.
49. Shimizu W, Kurita T, Suyama K, Aihara N, Kamakura S, Shimomura K: Reverse use dependence of human ventricular repolarization by chronic oral sotalol in monophasic action potential recordings. Am J Cardiol 1996;77:1004-1008.
50. Weissenburger J, Davy JM, Chezalviel F, Ertzbischoff O, Poirier JM, Engel F, Lainee P, Penin E, Motte G, Cheymol G: Arrhythmogenic activities of antiarrhythmic drugs in conscious hypokalemic dogs with atrioventricular block: Comparison between quinidine, lidocaine, flecainide, propranolol and sotalol. J Pharmacol Exp Ther 1991;259:871-883.
51. Vos MA, Verduyn SC, Gorgels APM, Lipcsei GC, Wellens HJ: Reproducible induction of early afterdepolarizations and torsade de pointes arrhythmias by d-sotalol and pacing in dogs with chronic atrioventricular block. Circulation 1995;91:864-872.
52. Verduyn SC, Vos MA, Van der Zande J, De Groot M, Leunissen JDM, Allessie MA, Wellens HJ: Electrophysiologic adaptations induced by chronic complete atrioventricular block predispose the canine heart for the induction of acquired torsade de pointes arrhythmias. (Abstract) Circulation 1995;92:I-504.
53. Shimizu W, McMahon B, Antzelevitch C: Sodium pentobarbital reduces transmural dispersion of repolarization and prevents torsade de pointes in models of acquired and congenital long QT syndromes. J Cardiovasc Electrophysiol 1999;10:156-164.
54. Sun ZQ, Eddlestone GT, Antzelevitch C: Ionic mechanisms underlying the effects of sodium pentobarbital to diminish transmural dispersion of repolarization. (Abstract) PACE 1997; 20(Pt II): 1116.
55. Shimizu W, Antzelevitch C: Differential response to β-adrenergic agonists and antagonists in LQT1, LQT2 and LQT3 models of the long QT syndrome. J Am Coll Cardiol 2000; (In press).
56. Kay GN, Plumb VJ, Arciniegas JG, Henthorn RW, Waldo AL: Torsade de pointes: The long-short initiating sequence and other clinical features: Observations in 32 patients. J Am Coll Cardiol 1983;2:806-817.
57. Locati EH, Maison-Blanche P, Dejode P, Cauchemez B, Coumel P: Spontaneous sequences of onset of torsade de pointes in patients with acquired prolonged repolarization: Quantitative analysis of Holter recordings. J Am Coll Cardiol 1995;25:1564-1575.
58. El-Sherif N, Zeiler RH, Craelius W, Gough WB, Henkin R: QTU prolongation and polymorphic ventricular tachyarrhythmias due to bradycardia-dependent early afterdepolarizations. Afterdepolarizations and ventricular arrhythmias. Circ Res 1988;63:286-305.
59. Akar FG, Van GX, Antzelevitch C, Rosenbaum DS: Optical maps reveal reentrant mechanism of torsade de pointes based on topography and electrophysiology of mid-myocardial cells. (Abstract) Circulation 1997;96:I-355.
60. Antzelevitch C, Sicouri S: Clinical relevance of cardiac arrhythmias generated by afterdepolarizations: The role of M cells in the generation of U waves, triggered activity and torsade de pointes. J Am Coll Cardiol 1994;23:259-277.